维普期刊资源整合服务平台（V6.5）

225篇 您的检索式：作者名="LEWIS EJ"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis显示文摘	HAN TS SCHWARTZ MM LEWIS EJ	2006	Lupus2006，15，2：	1
2	The effect of angio-tensin-converting-enzyme inhibition on diabetic nephropathy:the Collaborative Study Group显示文摘	Lewis EJ Humicker LG Bain RP	1993	N Engl J Med1993，329，：	1
3	The prognosis and pathogenesis of severe lupus glomerulonephritis显示文摘	Schwartz MM Korbet SM Lewis EJ	2011	Nephrol Dial Transplant2011，23，4：	1
4	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Lewis EJ Hunsicker LG Clarke WR	2001	N Engl J Med2001，345，12：	1
5	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Lewis EJ Hunsicker LG Clarke WR	2001	N Engl J Med2001，345，12：	1
6	Analysis of f-MRI and finger tracking training in subjects with chronic stroke显示文摘	Kimberley TJ Lewis SM Auerbach EJ	2002	Brain2002，125，4：	1
7	Renopro- tective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	LEWIS EJ HUNSICKER LG CLARKE WR	2001	N Engl J Med2001，345，12：	1
8	Sulodexide forkidney protection in type 2 diabetes patients with mi- croalbuminuria: A randomized controlled trial显示文摘	Lewis EJ Lewis JB Greene T	2011	Am J Kidney Dis2011，58，5：	1
9	Renoprotective effect of the angiotensin 2 receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Lewis EJ Hunsicker LG Clarke WR	2007	N Engl J Med2007，345，：	1
10	Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria:a randomized controlled trial显示文摘	Lewis EJ Lewis JB Greene T	2011	Am J Kidney Dis2011，58，5：	1
11	Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria:A randomized controlled trial显示文摘	Lewis EJ Lewis JB Greene T	2011	Am J Kidney Dis2011，58，5：	1
12	Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2diabetes 显示文摘	Lewis EJ Hunsicker LG Clarke WR	2001	N Engl J Med2001，345，12：	1
13	The highly effective use of topical zinc pyrithione in the treatment of psoriasis: A case report显示文摘	Crutchfield CE Lewis EJ	1997	Dermaltol Online J1997，3，1：	1
14	The role of angiotensin Ⅱ receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes显示文摘	Lewis EJ	2002	Am J Hypertens2002，15，10：	1
15	Primary focal segmental glomeraulqosclerosis: Clinical course and response to therapy显示文摘	Korbet SM Schwartz MM Lewis EJ	1994	Am J Kidney Dis1994，23，：	1
16	The burden of invasive early - onset neonatal sepsis in the United States 显示文摘	Weston EJ PontJo T Lewis MM	2011	Pediatr Infect Dis2011，30，5：	1
17	Renoprotective effect of the angiotensin - receptor antagonist irbesartan in patients with nephropathy due to type 2diabetes显示文摘	Lewis EJ Hunsicker LG Clarke WR	2001	N Engl J Med2001，345，：	1
18	Pyridorin in type 2diabetic nephropathy显示文摘	Lewis EJ Greene T Spitalewiz S	2012	J Am Soc Nephrol2012，23，1：	1
19	Electrical stimulation driving functional improvement and cortical changes in subjects with stroke显示文摘	Lewis SM Auerbach EJ	2004	Exp Briain Res2004，154，4：	1
20	Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist Irbesartan in patients with nephropathy due to type 2 diabetes显示文摘	Hunsicker LG Clarke WR	2001	N Engl J Med2001，345，11：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示